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Objective: Ongoing research is aimed at increasing cartilage tissue yield and quality from multipotent
mesenchymal stromal cells (MSC) for the purpose of treating cartilage damage in horses. Low oxygen
culture has been shown to enhance chondrogenesis, and novel membrane culture has been proposed to
increase tissue yield and homogeneity. The objective of this study was to evaluate and compare the effect
of reduced oxygen and membrane culture during in vitro chondrogenesis of equine cord blood (CB) MSC.
Methods: CBeMSC (n ¼ 5 foals) were expanded at 21% oxygen prior to 3-week differentiation in
membrane or pellet culture at 5% and 21% oxygen. Assessment included histological examination (H&E,
toluidine Blue, immunohistochemistry (IHC) for collagen type I and II), protein quantiﬁcation by hy-
droxyproline assay and dimethylmethylene assay, and mRNA analysis for collagen IA1, collagen IIA1,
collagen XA1, HIF1a and Sox9.
Results: Among treatment groups, 5% membrane culture produced neocartilage most closely resembling
hyaline cartilage. Membrane culture resulted in increased wet mass, homogenous matrix morphology
and an increase in total collagen content, while 5% oxygen culture resulted in higher GAG and type II
collagen content. No signiﬁcant differences were observed for mRNA analysis.
Conclusion: Membrane culture at 5% oxygen produces a comparatively larger amount of higher quality
neocartilage. Matrix homogeneity is attributed to a uniform diffusion gradient and reduced surface
tension. Membrane culture holds promise for scale-up for therapeutic purposes, for cellular pre-
conditioning prior to cytotherapeutic applications, and for modeling system for gas-dependent chon-
drogenic differentiation studies.
Crown Copyright  2014 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society
International. All rights reserved.Introduction
Articular hyaline cartilage in performance horses routinely
experience high intensity, repetitive loading. Spontaneous ortho-
paedic injuries resulting from these activities represent a major
cause of loss of performance days and wastage1. The intrinsic repair
capacity of cartilage is low and current palliative and surgical
intervention measures have not been able to demonstrate long-
term relief. Tissue replacement strategies using autologous sources
are limited by the difﬁculty of acquiring suitable graft material, and
the potential for donor site morbidity2. Because of theseT.G. Koch, Ontario Veterinary
, ON N1G 2W1, Canada.
o), mvickary@uoguelph.ca
014 Published by Elsevier Ltd onlimitations, cellular replacement strategies, such as tissue-
engineered implants or the injection of cells for tissue repopula-
tion have become a topic of interest.
Autologous chondrocytes isolated from hyaline cartilage have
been investigated as a source of replacement cells for focal cartilage
defect repair3. Improved healing was observed, however the limited
availability and loss of phenotype upon in vitro expansion remains a
problem. Hyaline cartilage characteristically contains a low number
of chondrocytes, and isolation protocols are only able to recover
approximately 22% of total available chondrocytes4. In vitro expan-
sion of the isolated chondrocytes are therefore required to obtain a
therapeutic cell number This expansion step is often associated with
a phenotypic alteration towards a ﬁbroblast-like morphology and
reduction of characteristic type II collagen and Aggrecan gene
expression5. Efforts to maintain or redifferentiate chondrocytes to
their native phenotype represents an ongoing ﬁeld of investigation6.behalf of Osteoarthritis Research Society International. All rights reserved.
Fig. 1. Study design. CBeMSC from ﬁve horses were expanded at 21% oxygen and then
differentiated in 21% and 5% oxygen in membrane and pellet culture. The passage
number at time of differentiation was 5 or 6. Pooled samples (four pellets, three
membranes) were used per each biological replicate for biochemical protein assays
and gene expression quantiﬁcation.
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as an alternative, or complementary, strategy for repopulating
chondrocytes during cartilage defect repair.MSC can be isolated from
a variety of sources, most commonly bone marrow (BM), adipose
tissue (AT), and peripheral or cord blood (CB)7,8. Deﬁning character-
istics of MSC are their ability for self-renewal and trilineage differ-
entiation into osteocytes, chondrocytes and adipocytes9. The main
advantage of MSC is their ability to maintain proliferative and dif-
ferentiation potential during in vitro expansion10,11. CBeMSC are
isolated from blood collected non-invasively from the umbilical
vessels at the time of birth. CBeMSC are cryotolerant and can be
cryobanked for later use. Establishment of CBeMSC cultures ahead of
time provides time for cell function screening and/or manipulation
for optimal efﬁcacy prior to clinical use. Most other MSC sources are
associated with some degree of invasive collection method such as
surgical AT harvesting or BM aspiration11. In addition, CBeMSC have
demonstrated greater chondrogenic potential than other MSC sour-
ces, such as BM and AT, in both humans and horses11e14.
Although MSC are readily acquired in large numbers and
capable of undergoing chondrogenic differentiation, the quality of
the generated neocartilage is inferior in comparison to normal
hyaline cartilage7,13. Majority of in vitro generated neocartilage is of
hybrid ﬁbro-hyaline phenotype and express hypertrophic markers
such as type X collagen15,16. To address this issue, various culture
parameters have been investigated. Two of the most important
factors are oxygen tension and culture method.
Compared with atmospheric oxygen levels ofw21%, the oxygen
concentration of in vivo cartilage is low, ranging between 1% and
10% depending on thickness and proximity to subchondral bone or
synovial ﬂuid17. Reduced oxygen conditions may therefore be
considered ‘normoxic’ for cartilage cell cultures, whereas those at
an atmospheric concentration of 21% represent a state of ‘hyper-
oxia’. The effect of low oxygen culture on chondrogenesis of MSC
has been studied in human and animal models, using articular
chondrocytes, BMeMSC and ATeMSC18e20. Low oxygen culture
was shown to enhance the phenotype of neocartilage generated
in vitro. In addition, hypoxia inducible factors (HIF), which have
been characterized as major response molecules to low oxygen,
have been correlated with chondrogenic markers such as Sox9 and
downstream Collagen IIA1and Aggrecan mRNA expression21.
Detailed review is given by Schipani22.
Another important parameter of in vitro chondrogenesis is the
mode of culture. Comparative chondrogenic potency studies are
generally conducted using pellet or micromass differentiation sys-
tems. Although pellet differentiation systems permit multiple cell
lines to be simultaneously screened for chondrogenic potency using
(for example, 96-well culture plates), the resulting 3D cell aggregates
are limited in size due to diffusion limitations: as pellet volume in-
creases, oxygen and nutrient diffusion diminishes. Pellets often
display areas of necrosis as well as cortical deposition of type I
collagen upon histological evaluation15. Consequently, there are
physical limitations to the overall number of chondrogenic cells that
can be generated from each pellet. With a starting MSC seeding
densityof2.5105e5.0105 cells, thepelletdifferentiation systemis
impractical for large scale MSC cartilage replacement strategies23. A
more recent approach for promoting MSC differentiation in vitro is a
membrane culture method24. Membrane culturing is a scaffold-free
method, wherein high numbers of MSC are seeded on a porous,
inert, collagen coated polytetraﬂuoroethylene (PTFE) membranes. In
contrast to pellets, the porosity of the membranes allow for more
efﬁcient diffusion between culture medium and developing tissues,
possibly contributing to tissue homogeneity. Lee and colleagues re-
ported the formation of a homogenous neocartilage,with abundance
of type II collagen and glycosaminoglycans (GAG) using membrane
culture methods for chondrogenic differentiation of ovine BMeMSC24. Comparable techniques using transwell inserts or agarose gel
substrates (termed self-assembly cultures) were associated with
similar ﬁndings25,26.
In this study, we hypothesized that mode of culture and oxygen
level signiﬁcantly affects the quality of in vitro chondrogenesis of
equine CBeMSC. To test this, we compared the effect of two
different oxygen concentrations during in vitro chondrogenesis of
CBeMSC in two different culture systems, pellets and membranes.
We determined that both oxygen concentration and culture
method inﬂuence chondrogenesis of CBeMSC, with low oxygen
membrane culturing yielding the most optimal outcome.
Materials and methods
CBeMSC isolation and expansion
The nuclear cells (NC)were isolated from ﬁve equine CB samples
using PrepaCyte-WBC (CytoMedical Design Group LLC; St. Paul,
MN, USA) according to manufacturer’s instructions. As previously
described7, the NC fraction was resuspended in isolation media
consisting of low-glucose Dulbecco’s modiﬁed Eagle medium (LG-
DMEM: Lonza; Walkersville, MD, USA), 30% Fetal Bovine Serum
(FBS) (Invitrogen; Burlington, ON, Canada), 100 IU/mL Penicillin
(Invitrogen; Burlington, ON, Canada), 0.1 mg/mL streptomycin
(Invitrogen; Burlington, ON, Canada), 2 mM L-glutamine (Sigmae
Aldrich; Oakville, ON, Canada) and 0.1 mM dexamethasone
(SigmaeAldrich; Oakville, ON, Canada). The cell fraction was then
plated on polystyrene tissue culture ﬂasks at a density of 1  106
cells/cm2 (SigmaeAldrich; Oakville, ON, Canada). Colonies were
trypsinized (0.04% trypsin-EDTA) at 70e80% conﬂuency and
further culture expanded in expansion medium (EM) consisting of
LG-DMEM, 30% FBS, 100 IU/mL Penicillin, 0.1 mg/mL streptomycin
and 2 mM L-glutamine at 21% oxygen. At passage 2 the cells were
cryopreserved in EM with 10% dimethylsulfoxide (DMSO) (Sigmae
Aldrich; Oakville, ON, Canada) by overnight control-rate freezing
canisters at 80C (Nalgene Mr. Frosty; Fischer Scientiﬁc; Mark-
ham, ON, Canada) before transfer to long-term storage in liquid
nitrogen.
Cryopreserved CBeMSC were thawed and plated at a cell den-
sity of 5,000 cells/cm2in EM at 21% oxygen. EM was completely
changed every 2e3 days. Cells were harvested at 60e80% con-
ﬂuency by enzymatic digestion with trypsin-EDTA and counted
with automated cell counter (Nucleocounter NC100, Mandel,
Guelph, ON, Canada) prior to chondrogenic differentiation.
Differentiation
Chondrogenic differentiation was carried out in both pellet
culture and membrane culture at 21% (referred to as normoxic
Fig. 2. Wet mass of generated tissue, adjusted for cell density, are presented as
means  95% CI. N ¼ 5, CB MSC isolated from ﬁve different foals. Letters denote sig-
niﬁcant differences between treatment groups. To account for the fact that membrane
culture uses eight times the amount of cells pellet culture does, membrane wet mass
was divided by 8. Regardless of the adjustment, membrane culture generated signif-
icantly higher tissue mass than pellet culture (P < 0.0001). 21% pellets to 5% pellets
P ¼ 0.30, 21% membranes to 5% membranes P ¼ 0.76. Culture method interaction
P < 0.0001, oxygen interaction P ¼ 0.059. 5% culture trends towards slightly higher wet
mass than 21% culture.
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study design.
Pellet culture: CBeMSC were suspended in chondrogenic me-
dium (CM) containing High Glucose Dulbecco’s modiﬁed Eagle
medium (HG-DMEM) (SigmaeAldrich; Oakville, ON, Canada),
200 mM Glutamax (Invitrogen; Burlington, ON, Canada), 100 mM
sodium pyruvate (Invitrogen; Burlington, ON, Canada), 1 ABAM
(Invitrogen; Burlington, ON, Canada), 0.1 mM dexamethasone
(SigmaeAldrich; Oakville, ON, Canada), 100 mg/mL ascorbic acid-2
phosphate (SigmaeAldrich; Oakville, ON, Canada), 40 mg/mL pro-
line (SigmaeAldrich; Oakville, ON, Canada),1 ITS (BD Biosciences;
Mississauga, ON, Canada), and 10 ng/mL transforming growth fac-
torb3 (R&D Systems; Minneapolis, MN, USA),at a concentration of
2.5  105 cells per 250 ml (per pellet). The cell suspension was then
placed in V-bottom polypropylene 96 well plates (Phenix; Candler,
NC, USA) and centrifuged at 200 g for 10 min and incubated in
either 5% or 21% oxygen From each cell culture, 10 replicate pellets
were made for each oxygen concentration.
Membrane culture: Protocol adapted from24. Brieﬂy, 12 mm
diameter, 0.2 mm pore size PTFE membrane inserts (Millipore;
Billerica, MA, USA) were coated with 100 ml of DMEM with 10%
human plasma ﬁbronectin (Millipore; Billerica, MA, USA) and left to
dry overnight. The following day coated membranes were sub-
jected to 10 min of UV treatment and placed in the incubator for
>6 h. We used 400 ml of EM containing 2.0  106 cells to seed the
top of the membrane, with an additional 600 ml of EM surrounding
the insert. All membranes were initially incubated overnight in 21%
oxygen. The following day, EM was replaced with 1.5 mL CM.
Membranes designated for 5% oxygen culture was incubated for 2 h
at 21% oxygen before transfer to a low oxygen incubator for the
remaining culture time. CMwas changed every 2e3 days.Wetmass
was determined at day 21 and adjusted for cell density, where the
mass of membrane generated tissues were divided by eight to ac-
count for the fact that the cell seeding density on the membrane
was eight times higher than pellet culture. Neocartilage from
membrane culture was adjusted to reﬂect only generated tissue,
minus the mass of membrane insert.
Histochemistry and immunohistochemistry (IHC)
Sample pellet and membrane cultures were ﬁxed in 10% neutral
formalin buffer overnight, dehydrated in isopropanol, and
embedded in parafﬁn. Serial 5 mm thick sections were prepared for
histochemistry and IHC. Sections were deparafﬁnised and rehy-
drated prior to staining. Toluidine blue was used to visualize GAG.
The stock solution contained 1 g toluidine blue powder (Sigmae
Aldrich; Oakville, ON, Canada) solubilized in 100 ml of 70% EtOH,
diluted to a 10% working solution with 1% NaCl (pH 2.0). Following
rehydration, sections were stained in toluidine blue working solu-
tion for 2 min and washed in three changes of distilled water. To
visualize overall tissue structure, a standard hematoxylin and eosin
(H&E) staining protocol was used27. IHC was used to identify type I
and type II collagen. Slides were deparafﬁnised and rehydrated, and
then subject to enzymatic antigen retrieval: 20 mg/mL proteinase K
at room temperature for 10 min and 1,600 U/mL hyaluronidase atTable I
Primer sequences for quantitative qPCR
Gene Forward primer
Collagen IA1 GAAAACATCCCAGCCAAGAA
Collagen IIA1 GACAACCTGGCTCCCAAA
Collagen XA1 CTTGGTTCATGGCGAGTTTT
HIF1a TGCATCTCCATCTCCTACCC
B2M TCGGGCTACTCTCCCTGACT
Sox9 ATCTGAAGAAGGAGAGCGAG37C for 20 min. Slides were then blocked with 3% FBS was at room
temperature for 30 min followed by quenching with 3% hydrogen
peroxide for 15 min. Slides were then incubated with primary
antibody (either mouse anti-type I collagen (Calbiochem, Cat#
CA60801-158) at dilution 1:250 or mouse anti-type II collagen
(Developmental studies Hybridoma Bank; Iowa city, Iowa, USA
Cat# II-II6B3) at dilution 1:50) overnight at 4C. Slides were then
washed with PBS 3 times for 2 min each and incubated with an
HRP-conjugated goat anti-mouse (DAKO; Burlington, ON, Canada)
for 1 h at room temperature. All slides were visualized with 3,3
diaminobenzidinechromogen (DAKO; Burlington, ON, Canada) and
a hematoxylin counterstain. Imaging was donewith Axiovision4.7.1
software.Biochemistry
Triplicate samples were snap frozen and stored at 80C.
Samples were then digested in 40 mg/mL papain (Invitrogen;
Burlington, ON, Canada), 20 mM ammonium acetate, 1 mM EDTA,
and 1 mM dithiolthreitol (DTT) (SigmaeAldrich; Oakville, ON,
Canada) for 48 h at 65C and frozen at 20C. Samples were then
thawed for quantiﬁcation using dimethylmethylene blue (DMMB)
dye binding assay for GAG content, hydroxyproline assay for total
collagen content and DNA quantitation kit for DNA quantiﬁcation.
For the DMMB assay, chondroitin sulfate (SigmaeAldrich; Oakville,
ON, Canada) was used to generate a standard curve. Results were
read at a wavelength of 525 nm. Hydroxyproline was used as a
proxy to estimate overall tissue collagen content with a conversion
factor of 10%24. In brief, the hydroxylproline assay was conducted as
follows: papain digested samples were hydrolyzed with 6 N HClReverse primer Accession number
TGATGTTTTGAGAGGCATGG XM_001492939.1 13
ACAGTCTTGCCCCACTTAC NM_001081764B 13
GTCCAGGGCTTCCATAACCT XM_001504101.1
CGCCAGGATCTTTGGATTTA XM_001493206.3
ATTTCAATCTCAGGCGGATG NM_001082502.2
TCAGAAGTCTCCAGAGCTTG XM_001498424.3 [47]
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standards were then incubatedwith 0.05 N chloramine T for 20min
at RT, 3.15 N perchloric acid for 5 min at RT and Ehlrichs reagent for
20 min at 60C. Absorbance was read at wavelength 560 nm. Hy-
droxyproline (SigmaeAldrich; Oakville, ON, Canada) was used as a
standard. DNA content was assessed using a commercial kit: DNA
quantitation kit e Fluorescence assay Cat# DNAQF-1KT (Sigmae
Aldrich; Oakville, ON, Canada) in a 96-well plate. The assay was
carried out according to manufacturer’s instructions. GAG and
collagen content was normalized to DNA content.
Quantitative qPCR
Samples were homogenized using a rotor stator (Powergen
1000) (Fischer Scientiﬁc; Markham, ON, Canada). Total RNA from
samples were isolated using the AmbionmirVanamiRNA isolation
kit (Invitrogen; Burlington, ON, Canada) according to manufac-
turer’s instructions. RNA concentration and purity was assessed
using Nanodrop ND-1000 spectrophotometer. RNA was treated
with DNase I (Invitrogen; Burlington, ON, Canada) and reverseFig. 3. Histological assessment by H&E stain (row 1), toluidine blue stain (row 2), and imm
sentative cell cultures at 400 times magniﬁcation. Membrane samples were sectioned whil
tissue; columns CeD). H&E staining show tissue morphology with round lacunae around c
fragmentation is found in column A, as outlined in white. Toluidine blue staining revealed lo
conﬁrmed by IHC. Insets for collagen I and II of control stains using only secondary antibodtranscribed using Superscript II Reverse Transcriptase (Invitrogen;
Burlington, ON, Canada) according to instructions with random
hexamers (Invitrogen; Burlington, ON, Canada). Quantitative po-
lymerase chain reaction (qPCR) was done using Ssofast
Evagreen Supermix (Bio-Rad; Hercules, CA, USA) with the CFX96
Touch Real-Time qPCR detection system (Bio-Rad; Hercules, CA,
USA) with a 10 mL reaction volume and 200 nm total primers.
Annealing temperature was determined to be 60C by running
temperature gradients for all primers. Standard curves were
generated with 4-fold serial dilution to determine primer efﬁ-
ciency. qPCR products were run on agarose gel, sequenced and
veriﬁed by BLASTN for sequence alignment. Genes were normal-
ized to beta-2-microglobulin (B2M) as a housekeeping gene for
relative expression levels28. Fold difference was compared to the
21% pellet sample. See Table I for primer information.
Statistics
GraphPad Prism 6.02 Software was used to perform statistical
analysis. Protein and wet mass data was analyzed by ordinary two-unostaining for type I (row 3) and type II collagen (row 4). Images are from a repre-
e still attached to the underlying PTFE membrane insert (brown structure next to the
ells and a high matrix to cell ratio in columns BeD. Indication of necrosis or nucleus
west proteoglycan content in 21% membranes (C). Presence of type I and II collagen was
y conﬁrm that non-speciﬁc staining did not occur.
Fig. 5. GAG content normalized to DNA content is presented as mean  95% CI. N ¼ 5,
CB MSC isolated from ﬁve different foals. Letters denote signiﬁcant differences be-
tween treatment groups. Signiﬁcance of 5% membranes compared to 21% pellets, 5%
pellets, and 21% membranes are P ¼ 0.0003, P ¼ 0.0008, and P ¼ 0.0001, respectively.
5% membranes show the highest accumulation of GAG content compared to other
groups. 21% pellets to 5% pellets P ¼ 0.98, 21% pellets to 21% membranes P ¼ 0.99, 5%
pellets to 21% membranes P ¼ 0.93. Interaction of culture method P ¼ 0.0098, inter-
action of oxygen P ¼ 0.0009.
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determine differences between treatment groups. Gene expression
data did not pass normality tests (ShapiroeWilk and Kolmogorove
Smirnov). Therefore, non-parametric KruskaleWallis ANOVA was
used with Dunnett’s post hoc testing for multiple comparisons.
Outliers were determined and excluded based on high z scores of
triplicate Ct values, or if the corresponding melting curve peak was
not consistent. Results are reported as means with 95% conﬁdence
intervals and signiﬁcance is assigned at P < 0.05.
Results
Wet mass
Membrane cultures resulted in signiﬁcantly greater wet mass
than pellet cultures [Fig. 2]. Although no differences were observed
between the different oxygen conditions for membrane cultures,
the meanwet mass of 5% pellet culture was greater than that of 21%
pellets (P ¼ 0.3).
Histology
Neocartilage most closely resembling hyaline cartilage was
produced at 5% membrane culture [Fig. 3(D)]. More speciﬁcally, the
resulting tissue had a homogenous extracellular matrix (ECM) and
highmatrix:cell ratio that was rich in both GAG and type II collagen.
In contrast, 21% pellet cultures exhibited low matrix:cell compo-
sition, heterogeneous matrix distribution with indication of ne-
crosis or fragmented nuclei and low indication of type II collagen
[Fig. 3(A), (D)]. At 21% oxygen, tissue generated using both mem-
branes and pellets yielded tissue with irregular staining for both
GAGs and type II collagen. Tissue collected from all four-culture
conditions demonstrated immunoreactivity to type I collagen.
Biochemistry
Consistent with the histological data, total collagen and GAG
content was highest in tissues generated using the 5% oxygen
membrane culture conditions [Figs. 4 and 5]. Membrane cultureFig. 4. Total collagen content normalized to DNA content is presented as mean  95%
CI with all differences P < 0.0001. N ¼ 5, CB MSC isolated from ﬁve different foals.
Letters denote signiﬁcant differences between treatment groups. Both 21% membrane
and 5% membranes accumulate more total collagen content than 21% pellet and 5%
pellets. 21% pellets to 5% pellets P ¼ 0.99, 21% membranes to 5% membranes P ¼ 0.95.
Culture method interaction P < 0.0001, oxygen interaction P ¼ 0.76.conditions at 21% also exhibited high total collagen content,
although GAG content was signiﬁcantly lower than 5% membranes.
In general, total collagen content was highest inmembrane cultures
regardless of oxygen tension [Fig. 4] and GAG content was
increased in 5% oxygen cultures, with highest GAG content in 5%
membrane culture [Fig. 5].
Gene expression analysis
Using qPCR, only collagen IIA1 demonstrated a signiﬁcantly
elevated expression levels, and only between 5% membrane cul-
tures and 21% pellet cultures [Fig. 6]. No signiﬁcant differences
were observed for mRNA expression of collagen IA1, collagen XA1,
Sox9, HIF1a [Fig. 7].
Discussion
Here we demonstrate that mode of membrane culture and ox-
ygen concentration are signiﬁcant contributors to in vitro generated
neocartilage. Under the set experimental groups, desirable cartilage
phenotype was maximized in membrane culture at 5% oxygen.
Cartilage phenotype from this culture condition was matrix rich
with homogenous distribution of ECM and rich in GAG and type II
collagen content. The current study was the ﬁrst to examine both
membrane culture and reduced oxygen for in vitro chondrogenesis,
and also the ﬁrst to examine the effects of these variables on equine
CBeMSC.
All treatment groups were immunopositive for type I collagen.
Type I collagen is a ﬁbrillar molecule that is characteristic of con-
nective tissue and ﬁbrocartilage, but not mature hyaline cartilage.
However, type I collagen (along with type II collagen) is initially
expressed during (in vivo) hyaline chondrogenesis29. During
chondrogenic differentiation of ovine BM-MSC, a steady decline of
collagen IA1 mRNA expression was observed from days 7 to 21,
while collagen IIA1 mRNA expressionwas sustained24. Our ﬁndings
represent a single, end-point assessment (conducted on day 21),
and therefore do not address the possibility of transient expression.
Future studies aimed at more thoroughly documenting the
Fig. 6. Gene expression showing collagen mRNA distribution as mean  95% CI with fold difference compared to 21% pellets. N ¼ 5, CB MSC isolated from ﬁve different foals. Letters
denote signiﬁcant differences between treatment groups. Signiﬁcance is observed in collagen IIA1 5% membranes to 21% pellets, P ¼ 0.03. No other signiﬁcant differences were
noted. Collagen IIA1: All other groups P > 0.9, except 5% membranes to 5% pellets P ¼ 0.7, 5% membranes to 21% membranes P ¼ 0.3. Collagen XA1: P > 0.9 in all groups except 5%
membranes to 5% pellets P ¼ 0.6. Collagen IA1: P > 0.9 in all groups.
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this apparent discrepancy.
Porous membrane culture for in vitro chondrogenesis has been
studied independently using similar techniques at 21% oxygen for
the purpose of overcoming limitations of the pellet method24,25.
Consistent with our ﬁndings, previous investigations have found
that membrane culture yields homogenous, hyaline-like neo-
cartilage24,25. In addition to advantages over pellet culture, such as
reduced surface tension and homogenous diffusion gradient,
membrane culture also presents scale up possibilities. The seeding
density was 2106million cells per 12mmmembrane insert in the
current study, an eight-time increase in initial seeding density over
pellet culture.
As evidenced by DMMB quantiﬁcation, the GAG content of 5%
membrane cultures were signiﬁcantly higher than all other culture
conditions. We speculate that membranes cultures permit a more
homogeneous diffusion of gases and nutrients/wastes, compared to
pellet cultures. Related to this, pellet cultures often developed
pockets of necrosis, and were structurally heterogeneous.
A deﬁning characteristic of membrane culture is disc shaped
tissue formation. To manipulate the tissue to form on top of PTFE
membranes as multi-cellular layers, membranes were coated with
adhesion proteins. Fibronectin was used in the present study and
collagen type IV in a previous study24. Despite this intermediate
coating step, tissue adherence to membranes was not always
consistent, presenting a current limitation of membrane culture.
Addition of a reversible factor Rho associated kinase (ROCK)inhibitor, Y27632 in the initial days of culture may prevent tissue
contraction, which we speculate to be a likely cause of tissue-
membrane separation. Y27632 has been shown to inhibit
spheroid formation of MSC, and was shown to upregulate cartilage
associated genes in the chondrogenic cell line ATDC530,31.
Reduced oxygen tension during chondrogenic differentiation of
MSC has been investigated in human, rat and ovine BMeMSC and
human and mouse ATeMSC19,20,32,33. In contrast, little is known
about the effect of reduced oxygen on the chondrogenesis of equine
CBeMSC. While reduced oxygen culture positively inﬂuences
in vitro chondrogenesis of BMeMSC in various species15,33e35 it did
not have the same effect on human and murine ATeMSC20,36. We
report here that, similar to BMeMSC, equine CBeMSC was
enhanced by reduced oxygen culture. The different ﬁndings may be
attributed to differences between the MSC sources or that MSC
cultures consist of heterogeneous cell population. Differential
response of the different MSC to reduced oxygen levels may be due
to differences in their respective niche. Accordingly, the AT envi-
ronment is at a higher oxygen level (10e15%) compared to BM
(<7%)37,38. To date, the oxygen level in the in vivo CB niche remains
unknown, although it is presumed to not exceed 8% oxygen in
congruence with the female reproductive tract39.
HIF1a mRNA transcripts were not signiﬁcantly upregulated in
the present study, although the mean mRNA expression level of
both HIF1a and Sox9 were increased in 5% culture compared to 21%
cultures. Consistent with our data, Adesida and colleagues did not
observe signiﬁcant difference in HIF1a mRNA levels between 21%
Fig. 7. Gene expression of transcription factors HIF1a and Sox9 is presented as
mean  95% CI with fold difference compared to 21% pellets. N ¼ 5, CB MSC isolated
from ﬁve different foals. Letters denote signiﬁcant differences between treatment
groups. No statistically signiﬁcant differences were observed. HIF1a: 5% membranes to
21% membranes P ¼ 0.5, 5% membranes to 21% pellets P ¼ 0.8, all others P > 0.9. Sox9:
5% pellets to 21% membranes P ¼ 0.6, all others P > 0.9.
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constitutively expressed22, thus possibly accounting for the non-
signiﬁcant differences in transcript levels of HIF genes. Alterna-
tively, Lafont and colleagues have proposed that HIF2a, and not
HIF1a, is responsible for Sox9 upregulation and downstream
effectors40.
It is also worth noting that cultures in reduced oxygen condi-
tions are subject to transient exposure to 21% oxygen during media
changes and/or ﬂuctuations in incubator gas levels, which may not
be representative of a true hypoxic environment. Although expo-
sure to normoxia was kept to a minimum, the long-term effect on
chondrogenic cultures is unknown. Furthermore, the selection of
5% oxygen to represent a hypoxic environment was based on values
used in the literature; however, varying levels may exhibit exag-
gerated or muted effects18,35,41. Clonally established and well-
characterized cell populations are needed to discriminate
whether the observed differences are due to the original MSC niche
or chance establishment of cell populations with variable
properties.
Temporal changes in gene expression levels in equine CBeMSC
during in vitro chondrogenesis have been reported16. Similar dy-
namic changes in gene expression levels were observed between
membrane and pellet cultures at days 7 and 14, however signiﬁcantdifferences were not observed by day 21 of chondrogenic culture24.
In the present study, end point assessment was conducted on day
21 cultures and no signiﬁcant differences were observed for gene
expression analysis between treatment groups, including groups in
reduced oxygen. Future assessment targeting temporal changes
would be productive in determining changes in response to mode
of culture as well as reduced oxygen.
Another plausible explanation for insigniﬁcant gene expression
data may be due to continuous chemical induction with a single
factor, TGFb3. Chondrogenic culture at high cell density with the
addition of TGFb3 mimics the in vivo initiation of chondrogenesis,
where the deﬁning event is cellular condensation and the expres-
sion of TGFb genes42. In contrast to the in vitro protocol of contin-
uous static application of TGFb3 in vivo MSC differentiation is
inﬂuences by a variety of different spatiotemporal cues. The tem-
poral administration of growth factors, such as timed addition or
removal of dexamethasone or TGFb3 was shown to inﬂuence ma-
trix components43,44. Continuous administration of solely TGFb3
may cause gene dysregulation. After chondrogenesis has been
initiated by TGFb3 in the ﬁrst few days, a cascade of endogenous
growth factors may come into play, possibly interacting with the
exogenous source of TGFb3.
Signiﬁcant donor variation is observed during gene expression
analysis in the present study as evidenced by large conﬁdence in-
tervals. Stringent determination of technical outlierswas applied on
raw CT values to avoid arbitrary dismissal of biological variation. A
larger study group may be necessary to conﬁrm true non-signiﬁ-
cance or show trends of differential response to treatment groups.
Alternatively, protein quantiﬁcation may show greater signiﬁcance
since ECM components require lengthy post translational modiﬁ-
cation before they reach their ﬁnal form45. Despite insigniﬁcant
changes in gene expression levels, type II collagen immunostaining
does show notable difference between 5% and 21% cultures.
In conclusion, we report that membrane culture under reduced
oxygen tension is a superior method to generate cartilage in vitro.
Membrane culture at low oxygen tension produced cartilage with a
desirable phenotype. The membrane culture method is well suited
for cytotherapeutic or tissue engineering, which requires large
amounts of homogenous tissue or large number of conditioned cells.
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